Sg Americas Securities, LLC Clovis Oncology, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$0.63 - $2.96 $14,966 - $70,317	-23,756 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$1.43 - $3.14 $16,663 - $36,590	-11,653 Reduced 32.91%	23,756 $48,000
Q4 2021 Feb 07, 2022	SELL	$2.7 - $4.76 $97,040 - $171,079	-35,941 Reduced 50.37%	35,409 $96,000
Q3 2021 Nov 01, 2021	BUY	$4.06 - $5.8 $212,220 - $303,171	52,271 Added 273.97%	71,350 $318,000
Q2 2021 Aug 12, 2021	SELL	$5.02 - $7.05 $308,479 - $433,222	-61,450 Reduced 76.31%	19,079 $111,000
Q1 2021 May 13, 2021	BUY	$4.81 - $10.34 $193,285 - $415,502	40,184 Added 99.6%	80,529 $565,000
Q4 2020 Feb 04, 2021	SELL	$4.13 - $6.41 $449,472 - $697,606	-108,831 Reduced 72.95%	40,345 $194,000
Q3 2020 Nov 09, 2020	SELL	$4.82 - $7.72 $255,537 - $409,283	-53,016 Reduced 26.22%	149,176 $870,000
Q2 2020 Jul 20, 2020	SELL	$5.69 - $9.69 $2.26 Million - $3.85 Million	-397,222 Reduced 66.27%	202,192 $1.37 Million
Q1 2020 Apr 30, 2020	BUY	$3.77 - $11.0 $2.26 Million - $6.59 Million	599,414 New	599,414 $3.81 Million
Q4 2019 Jan 28, 2020	SELL	$3.0 - $16.43 $141,081 - $772,653	-47,027 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$3.93 - $15.35 $167,127 - $652,774	-42,526 Reduced 47.49%	47,027 $185,000
Q2 2019 Jul 29, 2019	SELL	$12.81 - $25.67 $97,291 - $194,963	-7,595 Reduced 7.82%	89,553 $1.33 Million
Q1 2019 Apr 29, 2019	BUY	$17.66 - $30.28 $917,384 - $1.57 Million	51,947 Added 114.92%	97,148 $2.41 Million
Q4 2018 Feb 01, 2019	BUY	$11.63 - $32.67 $525,687 - $1.48 Million	45,201 New	45,201 $812,000
Q3 2018 Nov 06, 2018	SELL	$29.37 - $49.48 $79,445 - $133,843	-2,705 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$42.06 - $62.4 $431,914 - $640,785	-10,269 Reduced 79.15%	2,705 $123,000
Q1 2018 May 03, 2018	BUY	$50.12 - $67.72 $325,729 - $440,112	6,499 Added 100.37%	12,974 $685,000
Q4 2017 Jan 24, 2018	BUY	$57.69 - $84.58 $58,266 - $85,425	1,010 Added 18.48%	6,475 $440,000
Q3 2017 Nov 07, 2017	BUY	$67.17 - $84.81 $367,084 - $463,486	5,465	5,465 $450,000

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account